Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colloid osmotic pressure regulation during cardiopulmonary bypass in infants
NL-OMON32152Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in Cardiovascular Malformation (CVM) (2 arms), sponsored by Erasmus MC. Primary endpoints: Perioperative body weight change, Extravascular lung water index and 7 more. Started Apr 2008; status: active, not recruiting.
02
Drugs
albumin (human)
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on NL-OMON32152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32152.